Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Thrombolytics as effective as primary angioplasty and save $3,000/patient -- NEJM study.

This article was originally published in The Gray Sheet

Executive Summary

PRIMARY ANGIOPLASTY 5.6% MORTALITY RATE IN MITI REGISTRY MORE THAN DOUBLE the 2.6% in-hospital mortality rate reported in the 1993 Primary Angioplasty in Myocardial Infarction (PAMI) study, Nathan Every, MD, University of Washington, Seattle, et al. report in a study published in the Oct. 24 New England Journal of Medicine. In a comparison of angioplasty to thrombolysis as the initial treatment for MI patients, Every et al. found thrombolysis preferable, since the treatment yielded equivalent mortality rates and $3,000-per-patient cost savings compared to angioplasty.
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT006973

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel